VAGINAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED
Clinical trials for VAGINAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED explained in plain language.
Never miss a new study
Get alerted when new VAGINAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED trials appear
Sign up with your email to follow new studies for VAGINAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested against rare, Tough-to-Treat cancers
Disease control OngoingThis study is testing whether a combination of two immunotherapy drugs, atezolizumab and bevacizumab, can help control several rare types of advanced solid tumors. The trial is for adults whose cancer has spread or returned after other treatments. The goal is to see if this drug …
Matched conditions: VAGINAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Major trial aims to tame dozens of rare, neglected cancers with immune power combo
Disease control OngoingThis large national trial is testing whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help control over 50 different types of rare cancers that have few or no standard treatment options. It enrolled over 800 adults whose rare cancers had progressed …
Matched conditions: VAGINAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New hope for Tough-to-Treat gynecologic cancers in major national trial
Disease control OngoingThis large, late-stage trial is testing whether adding a new drug called triapine to the standard treatment of radiation and chemotherapy improves survival for women with advanced cervical or vaginal cancer. It will enroll 450 women to compare the new combination against the curr…
Matched conditions: VAGINAL SQUAMOUS CELL CARCINOMA, NOT OTHERWISE SPECIFIED
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC